BG103780A - Antitussive compositions - Google Patents

Antitussive compositions

Info

Publication number
BG103780A
BG103780A BG103780A BG10378099A BG103780A BG 103780 A BG103780 A BG 103780A BG 103780 A BG103780 A BG 103780A BG 10378099 A BG10378099 A BG 10378099A BG 103780 A BG103780 A BG 103780A
Authority
BG
Bulgaria
Prior art keywords
theobromine
admixture
additives
salts
solid
Prior art date
Application number
BG103780A
Other languages
Bulgarian (bg)
English (en)
Inventor
Dezso Korbonits
Peter Aranyi
Istvan Jelinek
Endre Mikus
Original Assignee
Dezso Korbonits
Peter Aranyi
Istvan Jelinek
Endre Mikus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dezso Korbonits, Peter Aranyi, Istvan Jelinek, Endre Mikus filed Critical Dezso Korbonits
Publication of BG103780A publication Critical patent/BG103780A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
BG103780A 1997-03-26 1999-10-04 Antitussive compositions BG103780A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700654A HUP9700654A2 (hu) 1997-03-26 1997-03-26 Teobromin tartalmú köhögéscsillapító készítmények
PCT/HU1998/000027 WO1998042322A2 (en) 1997-03-26 1998-03-20 Antitussive compositions

Publications (1)

Publication Number Publication Date
BG103780A true BG103780A (en) 2001-04-30

Family

ID=89994918

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103780A BG103780A (en) 1997-03-26 1999-10-04 Antitussive compositions

Country Status (23)

Country Link
US (1) US6348470B1 (no)
EP (1) EP0969843B1 (no)
JP (1) JP4450872B2 (no)
KR (1) KR100420370B1 (no)
CN (1) CN1251039A (no)
AT (1) ATE218868T1 (no)
AU (1) AU6741498A (no)
BG (1) BG103780A (no)
BR (1) BR9809057A (no)
CA (1) CA2284774C (no)
CZ (1) CZ295801B6 (no)
DE (1) DE69805983T2 (no)
DK (1) DK0969843T3 (no)
EA (1) EA001971B1 (no)
EE (1) EE9900428A (no)
ES (1) ES2178188T3 (no)
HU (1) HUP9700654A2 (no)
IL (2) IL131811A0 (no)
NO (1) NO994640L (no)
PL (1) PL190899B1 (no)
PT (1) PT969843E (no)
SK (1) SK285023B6 (no)
WO (1) WO1998042322A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030032484A (ko) * 2001-10-18 2003-04-26 롯데제과주식회사 발암 억제효능을 갖는 데오브로민
JP2004018512A (ja) * 2002-06-20 2004-01-22 Morinaga & Co Ltd 冷え性改善用組成物および冷え性改善用組成物の製造のためのカカオ豆加工物の使用
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
US20150216869A1 (en) * 2009-06-16 2015-08-06 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
US20150005325A1 (en) * 2009-06-16 2015-01-01 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
GB201014391D0 (en) 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0921803D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0919889D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0921805D0 (en) * 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
AU2015201845B2 (en) * 2009-11-13 2015-11-05 Infirst Healthcare Limited Drug combination with theobromine and its use in therapy
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
NL1040474C2 (en) 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
KR20160126217A (ko) 2015-04-23 2016-11-02 주식회사 진명 에프 엠 씨 용기 투입장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1113122B (it) * 1978-04-06 1986-01-20 Abc Ist Biolog Chem Spa Composizione farmaceutica ad attivita' antibrocospastica e antitosse
FR2531339A1 (fr) * 1982-08-04 1984-02-10 Dietlin Francois Nouveau procede d'obtention de formes pharmaceutiques a liberation programmee
HU197574B (en) 1986-10-09 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of derivatives of 3,7-dihydro-3-methil-7-//1,2,4-oxadiasole/-3-il/alkylenil/-1h-purin-2,6-dion and medical compositions containing these substances
GB2201591B (en) * 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
BR9407414A (pt) * 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
CA2227958A1 (en) * 1995-07-28 1997-02-13 Sekhar Mitra Compositions containing analgesics and antihistamines and methods for treating respiratory disorders

Also Published As

Publication number Publication date
ES2178188T3 (es) 2002-12-16
HUP9700654A2 (hu) 1999-09-28
EE9900428A (et) 2000-04-17
KR100420370B1 (ko) 2004-03-03
SK127399A3 (en) 2000-09-12
JP2001518928A (ja) 2001-10-16
IL131811A0 (en) 2001-03-19
WO1998042322A2 (en) 1998-10-01
AU6741498A (en) 1998-10-20
IL131811A (en) 2006-06-11
CA2284774C (en) 2005-12-06
NO994640D0 (no) 1999-09-24
BR9809057A (pt) 2000-08-01
CZ295801B6 (cs) 2005-11-16
JP4450872B2 (ja) 2010-04-14
EA001971B1 (ru) 2001-10-22
KR20010005642A (ko) 2001-01-15
PT969843E (pt) 2002-10-31
EP0969843A2 (en) 2000-01-12
DE69805983T2 (de) 2003-01-30
CA2284774A1 (en) 1998-10-01
CZ339199A3 (cs) 2000-04-12
DK0969843T3 (da) 2002-10-07
EA199900876A1 (ru) 2000-04-24
EP0969843B1 (en) 2002-06-12
PL335979A1 (en) 2000-06-05
CN1251039A (zh) 2000-04-19
US6348470B1 (en) 2002-02-19
ATE218868T1 (de) 2002-06-15
DE69805983D1 (de) 2002-07-18
SK285023B6 (sk) 2006-04-06
WO1998042322A3 (en) 1998-12-17
HU9700654D0 (en) 1997-05-28
NO994640L (no) 1999-09-24
PL190899B1 (pl) 2006-02-28

Similar Documents

Publication Publication Date Title
BG103780A (en) Antitussive compositions
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
EP0902789A4 (no)
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
IL141515A (en) Optically active pyridyl- 4h - 1, 2, 4 - oxadiazine derivative and its use in the treatment of vascular diseases and pharmaceutical composition comprising same
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
IL126175A0 (en) Method or treating heart failure with endothelin antagonists and pharmaceutical compositions containing the same
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
DE69102174D1 (de) Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe.
EP0443028A4 (en) NON-INJECTABLE CARCINOSTATIC AGENT FOR PREVENTING INFLAMMATION BY 5-FLUORURACIL AND METHOD FOR TREATING CANCER.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
DE69736955D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie